Literature DB >> 11906618

The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin.

Yoshiki Asayama1, Ken-ichi Taguchi Ki, Shin-ichi Aishima Si, Hidehiro Nishi, Kouji Masuda, Masazumi Tsuneyoshi.   

Abstract

BACKGROUND/AIM: To investigate the mode of progression of combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CC).
METHODS: An immunohistochemical study for E-cadherin (ECD) and alpha- and beta-catenins was performed on 29 cases of cHCC-CC.
RESULTS: Reduced expression of ECD was significantly correlated with the tumour grade of the hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) components, intrahepatic metastasis (IM) of HCC, IM of CC, and vascular invasion of CC (p < 0.05, respectively). There was a significant relationship between the reduced expression of beta-catenin and the tumour grade of HCC components (p < 0.05). Cases showing concurrent intrahepatic metastasis composed of HCC, CC, or both, numbered 6, 5, and 2, respectively. The expression patterns of ECD and beta-catenin of IM were similar to those of primary lesion in most cases. On the other hand, expression of ECD and beta-catenin of IM of HCC component were preserved, even though those of the primary sites were reduced in two cases and one case, respectively. ECD and beta-catenin were significantly correlated with tumour differentiation and tumour progression.
CONCLUSIONS: Preserved or recovered ECD and beta-catenin expression may be of beneficial effect for re-establishing the tissue architecture at the metastatic site.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11906618     DOI: 10.1046/j.0106-9543.2001.01580.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  12 in total

Review 1.  Combined hepatocholangiocarcinoma: case-series and review of literature.

Authors:  Vishal Bhagat; Milind Javle; Jihnhee Yu; Aarti Agrawal; John F Gibbs; Boris Kuvshinoff; Enriquetta Nava; Renuka Iyer
Journal:  Int J Gastrointest Cancer       Date:  2006

2.  Epithelial-mesenchymal transitions of bile duct epithelial cells in primary hepatolithiasis.

Authors:  Lijin Zhao; Rigao Yang; Long Cheng; Maijian Wang; Yan Jiang; Shuguang Wang
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

Review 3.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553

4.  Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters.

Authors:  Bo Zhai; He-Xin Yan; Shu-Qin Liu; Lei Chen; Meng-Chao Wu; Hong-Yang Wang
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

Review 5.  Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis.

Authors:  Jacqueline M Benjamin; W James Nelson
Journal:  Semin Cancer Biol       Date:  2007-09-04       Impact factor: 15.707

6.  Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas.

Authors:  Bo Zhai; He-Xin Yan; Shu-Qin Liu; Lei Chen; Meng-Chao Wu; Hong-Yang Wang
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

7.  The role of hepatocyte nuclear factor 4alpha in metastatic tumor formation of hepatocellular carcinoma and its close relationship with the mesenchymal-epithelial transition markers.

Authors:  Dianbo Yao; Songlin Peng; Chaoliu Dai
Journal:  BMC Cancer       Date:  2013-09-23       Impact factor: 4.430

8.  Prognostic significance of E-cadherin expression in hepatocellular carcinoma: a meta-analysis.

Authors:  Jiang Chen; Jie Zhao; Rui Ma; Hui Lin; Xiao Liang; Xiujun Cai
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

9.  Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma.

Authors:  Xing Yao; Xiang Wang; Zishu Wang; Licheng Dai; Guolei Zhang; Qiang Yan; Weimin Zhou
Journal:  Onco Targets Ther       Date:  2012-10-12       Impact factor: 4.147

10.  Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients.

Authors:  Sang-Jeon Lee; Song Yi Choi; Wun-Jae Kim; Meiying Ji; Taek-Gu Lee; Bo-Ra Son; Soon Man Yoon; Rohyun Sung; Eun Jeoung Lee; Sei Jin Youn; Seon Mee Park
Journal:  Diagn Pathol       Date:  2013-06-19       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.